Zapanta, John Bryle, and Charity Gorospe. 2025. “Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer After Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report”. Asian Pacific Journal of Cancer Care 10 (3), 989-92. https://doi.org/10.31557/apjcc.2025.10.3.989-992.